日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Cleavage of CAD by caspase-3 determines the cancer cell fate during chemotherapy.

化疗期间,caspase-3 对 CAD 的切割决定了癌细胞的命运

Ma Jingsong, Zhao Jiabao, Zhang Chensong, Tan Jinshui, Cheng Ao, Niu Zhuo, Lin Zeyang, Pan Guangchao, Chen Chao, Ding Yang, Zhong Mengya, Zhuang Yifan, Xiong Yubo, Zhou Huiwen, Zhou Shengyi, Xu Meijuan, Ye Wenjie, Li Funan, Song Yongxi, Wang Zhenning, Hong Xuehui

METTL10-Mediated PIAS3 Methylation Links Purine Metabolism to Gastric Cancer Progression.

METTL10介导的PIAS3甲基化将嘌呤代谢与胃癌进展联系起来。

Tan Jinshui, Zhou Huiwen, Ma Jingsong, Zhang Chensong, Tan Yuhua, Zhang Baoding, Zhao Jiabao, Cheng Ao, Yang Chengyu, Xu Meijuan, Zhou Shengyi, Xiong Yubo, Lin Zeyang, Pan Guangchao, Ye Wenjie, Zhong Mengya, Yang Yang, Zhuang Yifan, Li Shao-Wei, Deng Xianming, Hong Xuehui

Venetoclax confers synthetic lethality to chidamide in preclinical models with transformed follicular lymphoma.

在转化型滤泡性淋巴瘤的临床前模型中,维奈托克可赋予西达米德合成致死性

Zhong Mengya, Pan Guangchao, Tan Jinshui, Yao Jingwei, Liu Yating, Huang Jiewen, Jiang Yuelong, Zhu Depeng, Zhao Jintao, Xu Bing, Zha Jie

Orelabrutinib and venetoclax synergistically induce cell death in double-hit lymphoma by interfering with the crosstalk between the PI3K/AKT and p38/MAPK signaling.

Orelabrutinib 和 venetoclax 通过干扰 PI3K/AKT 和 p38/MAPK 信号通路之间的串扰,协同诱导双重打击淋巴瘤细胞死亡

Pan Guangchao, Zhong Mengya, Yao Jingwei, Tan Jinshui, Zheng Huijian, Jiang Yuelong, Tang Yuanfang, Zhou Hui, Qin Dongmei, Yu Xingxing, Liu Long, Li Zhifeng, Lin Zhijuan, Jiang Yirong, Xu Bing, Zha Jie